Literature DB >> 24577279

Placental pathology in early-onset and late-onset fetal growth restriction.

William Mifsud1, Neil J Sebire.   

Abstract

Several histopathological features are found more frequently in placentas from pregnancies complicated by fetal growth restriction (FGR), including villous infarction, maternal vascular changes and villous morphological alterations, although around one quarter of placentas associated with FGR lack any morphological abnormality on routine examination. Since similar changes may also affect clinically uncomplicated pregnancies, the positive predictive value of such findings for pathological FGR in an unselected case remains low. However, the pattern of placental pathologies varies with clinical subgroup. The combination of placental bed and parenchymal lesions in FGR with abnormal uterine artery Doppler velocimetry is essentially identical to preterm pre-eclampsia (PET), and there is an association between FGR with abnormal umbilical artery Doppler findings and lesions of fetal stem arteries and terminal villous hypovascularity. Conversely, placentas from pregnancies complicated by PET or FGR presenting at or near term have a significantly lower frequency of histological abnormalities compared to early-onset disease and absence of a distinctive biochemical profile. The histological placental findings in FGR are therefore varied, from morphologically unremarkable through to severe uteroplacental vasculopathy, with no single pathological feature associated with high sensitivity or specificity. Severe early-onset FGR, overlapping with severe early-onset PET, is mainly associated with features of impaired maternal uteroplacental perfusion secondary to defective extravillous trophoblast invasion, and its consequences. Late-onset FGR probably represents a more heterogeneous group with less characteristic histological changes. Future research using histopathological assessment of aggregated data from multiple studies into larger datasets with centralised pathology review will allow delineation of distinctive clinicopathological associations and further understanding of pathophysiology.

Entities:  

Mesh:

Year:  2014        PMID: 24577279     DOI: 10.1159/000359969

Source DB:  PubMed          Journal:  Fetal Diagn Ther        ISSN: 1015-3837            Impact factor:   2.587


  51 in total

1.  The RNA landscape of the human placenta in health and disease.

Authors:  Gordon C S Smith; D Stephen Charnock-Jones; Sungsam Gong; Francesca Gaccioli; Justyna Dopierala; Ulla Sovio; Emma Cook; Pieter-Jan Volders; Lennart Martens; Paul D W Kirk; Sylvia Richardson
Journal:  Nat Commun       Date:  2021-05-11       Impact factor: 14.919

2.  Predictive accuracy of the first trimester Doppler scan: a meta-study.

Authors:  Naira Roland Matevosyan
Journal:  Wien Med Wochenschr       Date:  2015-06-16

3.  Ultrasound detection of altered placental vascular morphology based on hemodynamic pulse wave reflection.

Authors:  Anum Rahman; Yu-Qing Zhou; Yohan Yee; Jun Dazai; Lindsay S Cahill; John Kingdom; Christopher K Macgowan; John G Sled
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-03-31       Impact factor: 4.733

4.  Antenatal and neonatal antecedents of learning limitations in 10-year old children born extremely preterm.

Authors:  Alan Leviton; Robert M Joseph; Elizabeth N Allred; T Michael O'Shea; Karl K C Kuban
Journal:  Early Hum Dev       Date:  2018-02-07       Impact factor: 2.079

5.  Exploring in vivo placental microstructure in healthy and growth-restricted pregnancies through diffusion-weighted magnetic resonance imaging.

Authors:  Nickie Andescavage; Wonsang You; Marni Jacobs; Kushal Kapse; Jessica Quistorff; Dorothy Bulas; Homa Ahmadzia; Alexis Gimovsky; Ahmet Baschat; Catherine Limperopoulos
Journal:  Placenta       Date:  2020-03-06       Impact factor: 3.481

6.  FIGO (international Federation of Gynecology and obstetrics) initiative on fetal growth: best practice advice for screening, diagnosis, and management of fetal growth restriction.

Authors:  Nir Melamed; Ahmet Baschat; Yoav Yinon; Apostolos Athanasiadis; Federico Mecacci; Francesc Figueras; Vincenzo Berghella; Amala Nazareth; Muna Tahlak; H David McIntyre; Fabrício Da Silva Costa; Anne B Kihara; Eran Hadar; Fionnuala McAuliffe; Mark Hanson; Ronald C Ma; Rachel Gooden; Eyal Sheiner; Anil Kapur; Hema Divakar; Diogo Ayres-de-Campos; Liran Hiersch; Liona C Poon; John Kingdom; Roberto Romero; Moshe Hod
Journal:  Int J Gynaecol Obstet       Date:  2021-03       Impact factor: 3.561

7.  Maternal plasma angiogenic index-1 (placental growth factor/soluble vascular endothelial growth factor receptor-1) is a biomarker for the burden of placental lesions consistent with uteroplacental underperfusion: a longitudinal case-cohort study.

Authors:  Steven J Korzeniewski; Roberto Romero; Tinnakorn Chaiworapongsa; Piya Chaemsaithong; Chong Jai Kim; Yeon Mee Kim; Jung-Sun Kim; Bo Hyun Yoon; Sonia S Hassan; Lami Yeo
Journal:  Am J Obstet Gynecol       Date:  2015-12-11       Impact factor: 8.661

8.  Extracellular vesicles generated by placental tissues ex vivo: A transport system for immune mediators and growth factors.

Authors:  Wendy Fitzgerald; Nardhy Gomez-Lopez; Offer Erez; Roberto Romero; Leonid Margolis
Journal:  Am J Reprod Immunol       Date:  2018-05-04       Impact factor: 3.886

9.  Disease-Modifying Drug Possibly Linked to Placental Insufficiency: Severe placental complications in a pregnant woman with multiple sclerosis.

Authors:  Sultan M Salahudheen; Muzibunnisa A Begam
Journal:  Sultan Qaboos Univ Med J       Date:  2016-08-19

10.  Comparison of Efficiency and Function of Vascular Endothelial Growth Factor Adenovirus Vectors in Endothelial Cells for Gene Therapy of Placental Insufficiency.

Authors:  Carlo Rossi; Mark Lees; Vedanta Mehta; Tommi Heikura; John Martin; Ian Zachary; Rebecca Spencer; Donald M Peebles; Robert Shaw; Minna Karhinen; Seppo Yla-Herttuala; Anna L David
Journal:  Hum Gene Ther       Date:  2020-11       Impact factor: 5.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.